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Abstract

Background: To understand the molecular basis of temporomandibular joint (TMJ) pathologies, we aimed to investigate the lubricin levels in the TMJ synovial fluid (SF) of patients with mild to severe internal derangements
(IDs).
Material and Methods: A total, 34 joints were the study group. Only patients, with a Wilkes stage of III, IV and V
were included, in this sample. Control group consisted of SF from eight joints, from patients undergoing to orthognatic surgery. Concentrations of lubricin in the SF from both samples were measured using ELISA system.
Results: The mean lubricin concentration was 7.029 ± 0.21 µg/mL in stage III patients; 5.64 ± 0.10 µg/mL in stage
IV patients, and 4.78 ± 0.11 µg/mL in stage V patients. The lubricin levels from stage IV and stage V patients differed significantly (P ≤ 0.001) from those of control subjects. Lubricin levels were inversely correlated with age
and to VAS score.
Conclusions: The results of this cross-sectional study highlight the relationship between disease severity and the
levels of lubricin in TMJ SF. Our findings suggest that novel biotherapeutic approaches, including the administration of recombinant lubricin in the joint cavity, for the treatment of TMJ diseases can be developed.
Key words: Lubricin, TMJ, derangements, synovial fluid.
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Introduction

degradation mediators under mechanical loading conditions (5). Several molecules that are present in the SF contribute to joint lubrication, particularly boundary lubrication; one such molecule is lubricin (4,6). A longstanding
TMJ disc injury affects lubricin expression in the TMJ
disc tissue (7). In an investigation of lubricin levels in
the SF of patients with TMJ disorders, lubricin was down
regulated in patients affected by OA versus patients affected by displaced disc with or without reduction (8).
However, any correlation of lubricin levels with Wilkes’s
stages, signs and/or symptoms was not provided.
In order to gain a better understanding of the degenerative change mechanism and the molecular basis of OA
etiopathogenesis, we decided to use this study to investigate the lubricin levels in the TMJ SF of patients with
mild to severe ID. The observed lubricin concentrations
were, therefore, correlated with the Wilkes stages, pa-

Temporomandibular disorders (TMDs) are conditions
that affect the temporomandibular joint (TMJ) and related musculoskeletal structures. Normally, these disorders are divided into classical myofascial pain, internal
derangement (ID), and osteoarthrosis (OA) (1).
Clinically speaking, mild TMJ-ID is characterized by
disc displacement, with or without osseous remodeling,
whereas severe derangement includes disc or attachment perforations, osseous remodeling, and osteoarthritic changes. OA is a degenerative change in the TMJ
that alters its physical and functional properties, the disorder leads to the reversible, and subsequently irreversible, inability of the TMJ to withstand loading stress.
Wilkes proposed the classification, which is commonly
used for describing the severity of TMJ diseases (Table
1) but is also extremely useful for diagnosis (2).
Table 1. Wilkes classification of TMJ diseases.

Stage I Early
Stage II Early/
Intermediate
Stage III
Intermediate

Patients with painless clicking, no restricted motion, slightly forwarded disc
(reducing), and normal osseous contours
Patients with occasional painful clicking, intermittent locking, headache, slightly
forwarded disc (reducing), with early disc deformity, and normal osseous contours
Patients with frequent pain, joint tenderness, locking, headache, restricted motion, painful chewing (characteristics), anterior disc displacement, moderate to
marked disc thickening, and normal osseous contours

Stage IV
Intermediate/
Late

Patients with chronic pain, headache, restricted motion, anterior disc displacement, marked disk thickening, and abnormal bone contours

Stage V Late

Patients with variable pain, joint crepitus, anterior disc displacement with disc
perforation and gross deformity, and degenerative osseous changes

Wilkes’s staging is based on the progression of the gross
pathology of ID and OA in the joint. The Wilkes classification consists of five stages based on clinical, radiologic and intraoperative findings; it varies from a slight
forward displacement with symptom-free normal joints
to degenerative arthritic changes with severe clinical
symptoms (3). The chronic degenerative tissue changes
whereas OA experienced in TMJ disorders may affect
articular cartilage and adjacent joint connective tissue
responses, including the articular capsule and ligaments, synovial membrane, and the articular bone.
Specific circumstances have been linked to the development of TMJ-OA, including impairment of the synovial
fluid (SF) (2,4). Indeed, compromised lubrication in the
TMJ is associated with altered frictional properties and
surface wear of the condylar cartilage, which is accompanied by the release of pro-inflammatory and matrix

tient ages, visual analog scale (VAS) scores, and maximum interincisal mouth (MIO) opening measurements.

Material and Methods

- Subjects
The study subjects were selected from a consecutive
series of patients who attended the Orofacial Pain and
TMD Clinic in the Department of Oral and Maxillofacial Surgery at the Pontifical Catholic University of
Paraná, Brazil, from February 2009 to May 2013.
This cross-sectional study was approved by the Ethical
Committee on Research at Pontifical Catholic University of Paraná, according to Resolution 196/96 of the
National Health Council, and it was approved under
registration number 104. A signed informed consent
form was also obtained from each patient before collecting the TMJ SF.
e794
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Clinical TMD was diagnosed according to the clinical
diagnostic criteria published by Truelove et al. (9). All
patients were subject to a standard pre-operative examination by the same clinician and were then asked to
fill in a VAS to assess pain with endpoint scores going
from 0 (no pain) to 10 (worst pain ever experienced).
The MIO opening was measured with a ruler to the
nearest millimeter. Joint sounds were evaluated by using finger palpation and a stethoscope. Joint and muscle
tenderness were also assessed by finger palpation. The
diagnosis was based on the clinical status but was also
supported by the findings from computed tomography,
magnetic resonance imaging, or both (Fig. 1). Following
these evaluations, the patients were classified according
to their appropriate Wilkes stage (2).
The inclusion criteria were a diagnosis of Wilkes stage
(2) III, IV, or V. The exclusion criteria were as follows:
a diagnosis of Wilkes stage I or II, systemic arthropathy, use of nonsteroidal anti-inflammatory drugs, and/
or history of trauma.
A total number of 34 joints from 32 patients (5 males
and 27 females; age range: 21-62 years; mean age: 34 ±
11.04) were included in the study group. Two patients
included in this study group had bilateral TMJ involvement. The preoperative clinical signs and symptoms of
the patients, defined according to the Wilkes stages, are
shown in table 2. The mean duration of these symptoms
was 4 years (range: 0.7-18 years).
The control group consisted of SF from eight joints
from eight patients (two males and six females; age
range: 28-54 years, (mean age: 42.3 ± 9,5) without signs

or symptoms of TMJ disorders. These control patients
were volunteers who were undergoing orthognathic surgery and had agreed to participate in the study.
- Collection of the TMJ SF
Prior to arthrocentesis (under local anesthesia), the SF
samples were collected from the superior joint cavity
using diluted aspiration as previously described. Briefly, the skin surface was disinfected and SF was aspirated from the affected side of the patients with TMJ
disorder and the right-sided TMJ of the control subjects.
Physiological saline (1.0 mL) was injected into the upper joint cavity using a 21-gauge hypodermic needle.
The SF was collected using the push-and-pull method,
which involves repeating the aspiration and injection
approximately five times. Afterwards, the collected SF
was centrifuged (4°C, 10 min, 1500 ×g) prior to measuring the lubricin concentrations. Only the supernatant
was separated and stored in a deep freezer (-80°C). The
total amount of protein from each sample was determined by measuring the optical density at 280 nm, with
bovine serum albumin used as the standard.
- Enzyme-linked immunosorbent assay (ELISA) analysis of lubricin in the SF
Concentrations of lubricin in the SF were measured
using a commercially available ELISA system (Pierce
Biotechnology, Rockford, IL, USA) as previously described, (10,11) following the manufacturer’s instructions for the quantitative determination of lubricin. The
assay sensitivity of lubricin was 3.25 pg/mL. Concentrations of lubricin less than minimal sensitivity were
considered as 0 pg/mL. The level of lubricin was de-

Fig. 1. MRI findings of Anterior disc displacement without reduction.
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Table 2. Patient background data. Abbreviations: F: Female; M: Male; MIO: Maximum interincisal opening; visual analog
scale (0-100).

Wilkes
Classification

Age (yrs)

Gender

Disease side

Lubricin
(pg/ml)

VAS

MIO

Stage III

26

F

L

6.9

76

24

Stage III

32

F

R

6.9

68

21

Stage III

21

F

R

7.2

72

14

Stage III

34

F

L

7.4

68

7

Stage III

24

F

R

6.9

75

18

Stage III

27

F

R

7.1

69

11

Stage III

31

F

L

6.8

74

9

Stage IV

60

F

R

6.2

70

14

Stage IV

32

M

R

5.6

73

22

Stage IV

27

F

R

6.1

78

12

Stage IV

45

F

L

5.4

79

26

Stage IV

22

F

R

6

83

14

Stage IV

25

F

L

5.7

68

11

Stage IV

32

M

R

5.6

74

5

Stage IV

41

F

L

5.2

74

8

Stage IV

26

F

L

5.2

79

21

Stage IV

33

F

R

5.6

82

18

Stage IV

28

F

R

5.5

75

14

Stage V

59

F

L

4.2

84

11

Stage V

34

F

R

4.9

89

20

Stage V

42

M

L

5.4

78

6

Stage V

35

F

R

5.2

91

13

Stage V

35

F

R

4.4

91

13

Stage V

26

F

R

5

86

24

Stage V

35

F

R

4.8

88

18

Stage V

46

F

R

5.6

77

5

Stage V

32

M

L

5.2

80

9

Stage V

32

M

R

5.1

80

9

Stage V

24

F

L

4.3

86

26

Stage V

35

F

L

4.8

87

24

Stage V

62

F

R

4.5

81

22

Stage V

29

F

R

4.9

83

15

Stage V

40

M

L

4.1

89

17

Stage V

58

F

R

4.2

88

19

fined as its concentration per milligram of total protein
in the SF.
- Statistical analysis
Mean values and standard deviations were calculated
for lubricin levels in TMJ SF in each subgroup of the
sample (i.e., Wilkes stages III, IV, and V). A Shapiro–
Wilk test was used to test for normality. Data had a

non-parametric distribution, therefore, Mann–Whitney
U tests were used to evaluate any statistical differences
among the lubricin levels of the three Wilkes stage subgroups and the control group.
A non-parametric Spearman’s rank correlation test (rho)
was used to obtain the correlation coefficient from correlations between lubricin levels and patient ages, VAS
e796
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scores, and MIO. P-values ≤ 0.05 were considered statistically significant. All data were analyzed using the SPSS
program (SPSS release 16.0; SPSS, Chicago, IL, USA).

as the Wilkes stage became more severe. Specifically,
the mean lubricin concentration was 7.029 ± 0.21 µg/
mL in stage III patients; 5.64 ± 0.10 µg/mL, in stage
IV patients, and 4.78 ± 0.11 µg/mL in stage V patients.
The lubricin levels from stage IV and stage V patients
differed significantly (P ≤ 0.001) from those of control
subjects, (Table 3).
The lubricin levels were inversely correlated with age
(rho = −0.445; P ≤ 0.008) (Fig. 2) and to VAS score (rho
= −0.823; P ≤ 0.009) (Fig. 3); on the other hand, there
was no statistically significant correlation between the
lubricin levels and MIO.

Results

The distribution of patients according to the Wilkes
classification was as follows:
seven patients were stage III, 11 patients were stage IV,
and 14 patients were stage V (Table 2).
The SF lubricin concentration obtained from normal
joints was 7.425 ± 0.34 µg/mL. On the contrary, in the
study group the lubricin levels progressively decreased

Table 3. Statistical differences and levels of significance, among the lubricin concentrations in the three Wilkes stage
subgroups and the control group according to Mann–Whitney U tests.

control
Stage III
Stage IV
Stage V

control

Stage III

Stage IV

Stage V

-

N.S.

P≤0.001

P≤0.001

N.S

-

P≤0.001

P≤0.001

P≤0.001

-

P≤0.001

P≤0.001

P≤0.001

-

P≤0.001
P≤0.001

Fig. 2. Correlation analysis of lubricin concentrations and patient age.
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Fig. 3. Correlation analysis of lubricin concentrations and VAS.

Discussion

by lubricin catabolism, and down-regulation due to elevated inflammatory cytokines levels (17). Therefore,
lubricin is deficient in arthritic joints (11,19,20).
As far as TMJ is concerned, some studies on animals
have highlighted the essential role of lubricin in the
maintenance of TMJ integrity and in the earlier onset
of TMJ-OA (21,22). However, very few studies have investigated lubricin expression in human TMJ fluid and
tissues (7,8). From these few investigations, it appears
that lubricin was down-regulated in diseased TMJ disc
tissue from patients with IDs (7). Moreover, lubricin
concentrations in SF were apparently lower in patients
with OA but not in patients with IDs (8).
Findings from our study are in agreement with this previous data. We also demonstrated that the patients’ lubricin levels progressively decreased as their Wilkes stage
became more severe and that the lubricin levels were inversely correlated with patient age and VAS (but not with
MIO). Our results are corroborated by previous findings
obtained in studies from joints other than the TMJ, these
studies demonstrated that Lubricin/PRG4 gene expression is affected by aging, which may lead to altered mechanical joint function in elderly subjects (23).
The discovery that lubricin levels are inversely correlated with pain (i.e., with VAS scores) is a novel result
in the present study. It could be argued that this latter
result could be somehow related to the release of proinflammatory and matrix degradation mediators in the
SF of patients with TMJ disease.
Regarding this, previous studies reported that in TMJ
SF, the TNF-α levels increased in patients with IDs as

Articular cartilage functions as a surface that allows
joint movement under conditions of extremely low friction. Hyaluronic acid (HA) and lubricin are two major
joint lubricants that protect surfaces from wear (12).
The mechanically trapped HA–lubricin complex acts
as an effective chemically bound lubricant that slightly
reduces friction forces but more importantly eliminates
wear damage to the cartilage surfaces. Thus, the lubrication system as a whole requires both HA and lubricin
to function optimally (11-13). Lubricin is a proteoglycan
that is specifically synthesized and expressed by articular chondrocytes of the superficial zone (14).
Lubricin may be degraded and its synthesis may be reduced due to a loss of joint lining cells (the major lubricin producers) or inhibition of lubricin synthesis by
inflammatory cytokines. Indeed, numerous cytokines
and growth factors are reportedly involved in the regulation of lubricin expression. For example, TGF‑β1, an
anabolic factor, up-regulates the synthesis and surface
localization of lubricin, whereas IL‑1β or TNF-α downregulates the production of lubricin (15,16).
It has also been suggested that the altered joint mechanics in knee injuries can lead to decreased lubricin expression in the superficial layer as well as decreased lubricin coating of the surface of articular cartilage. These
effects are significant risk factors for the development
of secondary OA (17,18). In fact, following a traumatic
knee injury, articular cartilage surfaces are predisposed
to wear-induced damage because of the resultant changes in joint lubricating mechanisms, which are mediated
e798
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the stage of the disease progresses, pain levels (VAS
scores) increased too. Thus, AA (24) concluded that
TNF-α may contribute to the pathogenesis of TMJ cartilage and bone degeneration. In addition, TNF-α induces the production of other pro-inflammatory cytokines
such as IL-1, IL-6, and IL-8 (25), which in turn determines the down-regulation of lubricin (17).
Further evidence is provided from another study which
demonstrated that under mechanical loading conditions, there is a release of pro-inflammatory and matrix
degradation mediators which are associated with altered frictional properties and surface wear of condylar
cartilage (5).
Thus, given these previous findings and our present
data, it can be hypothesized that in the TMJ, similar to
other joints, both altered loading and inflammation can
lead to decreased lubricin levels, which in turn play a
role in the onset of degenerative changes in joints.
In conclusion, the results of this cross-sectional study
highlight the relationship between disease severity and
the levels of lubricin in TMJ SF. Significantly, our findings suggest that novel biotherapeutic approaches for
the treatment of OA, including the administration of
recombinant lubricin in the joint cavity, could be developed in future for the prevention of cartilage degeneration.
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